Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3223]

Possible new cancer treatment target discovered

Possible new cancer treatment target discovered

$FDA approves pemigatinib for relapsed or refractory myeloid/lymphoid neoplasms with FGFR1 rearrangement$

FDA approves pemigatinib for relapsed or refractory myeloid/lymphoid neoplasms with FGFR1 rearrangement

FDA approves ibrutinib for paediatric patients with chronic graft versus host disease, including a new oral suspension

FDA approves ibrutinib for paediatric patients with chronic graft versus host disease, including a new oral...

AI model that reduces cost and time and increasing accuracy of cancer diagnosis

AI model that reduces cost and time and increasing accuracy of cancer diagnosis

There’s a better way to detect high-risk medications in older adults with cancer according to new study

There’s a better way to detect high-risk medications in older adults with cancer according to new study

Why do men face a higher risk of most types of cancer than women?

Why do men face a higher risk of most types of cancer than women?

Protein that may predict future diabetes risk and death from cancer identified

Protein that may predict future diabetes risk and death from cancer identified

New patent-pending method mass-produces antitumour cells to treat blood diseases and cancer

New patent-pending method mass-produces antitumour cells to treat blood diseases and cancer

Leukaemia vulnerability discovered causing drug sensitivity

Leukaemia vulnerability discovered causing drug sensitivity

Custom molecule sBCMA-Fc V3 halts growth of multiple myeloma and diffuse large B cell lymphoma in mice

Custom molecule sBCMA-Fc V3 halts growth of multiple myeloma and diffuse large B cell lymphoma in mice

More from ecancer